PAF-RECEPTOR .3. CONFORMATIONAL AND ELECTRONIC-PROPERTIES OF PAF-LIKE AGONISTS AND ANTAGONISTS

被引:10
作者
LAMOTTEBRASSEUR, J
DIVE, G
LAMOURI, A
HEYMANS, F
GODFROID, JJ
机构
[1] UNIV PARIS 07, PHARMACOCHIM MOLEC LAB, 2 PL JUSSIEU, F-75251 PARIS 05, FRANCE
[2] INST CHIM, MICROBIOL LAB, LIEGE, BELGIUM
[3] INST PHYS, CRISTALLOG LAB, LIEGE, BELGIUM
[4] INST PHARM, CHIM PHARMACEUT LAB, LIEGE, BELGIUM
关键词
PAF AGONIST; PAF ANTAGONIST; CONFORMATION; ELECTROSTATIC MAP; 3-DIMENSIONAL; SYNTHESIS;
D O I
10.1016/0005-2760(91)90236-B
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to compare electronic and conformational properties of PAF-agonists and PAF-antagonists, 14 analogues structurally related to PAF were studied. A common conformation of the glycerol backbone was present in all agonists and all constrained or flexible antagonists. The distinction between agonists and antagonists appears to be casted on position-2 where the folded conformation of the substituent for agonists should be the most probable. In position-3 the gauche conformation can be adopted by all the analysed compounds. The electrostatic potential well at -30 kcal/mol stretches to the carbonyl group in position-2 in the folded conformation of the agonists. On the contrary, in constrained antagonists, a second negative zone appears around the carbamate group. Given the modelling results, the triethylammonium PAF analogue considered in literature as a weak agonist, was resynthesized and proved to be more potent than previously reported. These experimental results confirm our hypothesis in terms of a common conformation of agonist and antagonist PAF-like molecules.
引用
收藏
页码:91 / 105
页数:15
相关论文
共 43 条
[1]  
ALLINGER NL, 1977, QUANTUM CHEM PROGRAM
[2]  
BENVENISTE J, 1979, CR ACAD SCI D NAT, V289, P1037
[3]   ANTIHYPERTENSIVE ACTIVITY OF AN ALKYL ETHER ANALOG OF PHOSPHATIDYLCHOLINE [J].
BLANK, ML ;
SNYDER, F ;
BYERS, LW ;
BROOKS, B ;
MUIRHEAD, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 90 (04) :1194-1200
[4]   ADDITIONAL TECHNIQUES FOR THE TOTAL SYNTHESIS OF PAF-ACETHER [J].
BORREL, MC ;
BROQUET, C ;
HEYMANS, F ;
MICHEL, E ;
REDEUILH, C ;
WICHROWSKI, B ;
GODFROID, JJ .
AGENTS AND ACTIONS, 1982, 12 (5-6) :709-710
[5]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[6]   PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS [J].
BRAQUET, P ;
GODFROID, JJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (10) :397-403
[7]  
BRAQUET P, 1987, PLATELET ACTIVATING, P191
[8]   H-1-NMR AND C-13-NMR STUDIES OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER) AND ANALOGS - INFLUENCE OF SOLVENT [J].
CONVERT, O ;
MICHEL, E ;
HEYMANS, F ;
GODFROID, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 794 (02) :320-325
[9]   DUAL BINDING MODES TO THE RECEPTOR FOR PLATELET ACTIVATING FACTOR (PAF) OF ANTI-PAF TRANS-2,5-DIARYLFURANS [J].
COREY, EJ ;
CHEN, CP ;
PARRY, MJ .
TETRAHEDRON LETTERS, 1988, 29 (24) :2899-2902
[10]  
DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355